Who owns the IMBRIA PHARMACEUTICALS trademark?

The IMBRIA PHARMACEUTICALS trademark is owned by Imbria Pharmaceuticals, Inc..

What is the serial number for IMBRIA PHARMACEUTICALS?

The USPTO serial number for IMBRIA PHARMACEUTICALS is 88399984.

What is the registration number for IMBRIA PHARMACEUTICALS?

IMBRIA PHARMACEUTICALS is registered under USPTO registration number 0.

IMB

USPTO Trademark Record

ABANDONED

IMBRIA PHARMACEUTICALS

Q: What class is the IMBRIA PHARMACEUTICALS trademark registered in?

The IMBRIA PHARMACEUTICALS trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 005 (Pharmaceuticals, medical & veterinary preparations).

SN 88399984·Reg 0·Filed Apr 24, 2019

Owner Imbria Pharmaceuticals, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

IMBRIA PHARMACEUTICALS (Serial No. 88399984), Registration No. 0, is a abandoned US trademark filed on Apr 24, 2019 by Imbria Pharmaceuticals, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

IMBRIA PHARMACEUTICALS (Reg. #0) is an abandoned US trademark that was filed in 2019 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 005 (Pharmaceuticals, medical & veterinary preparations) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research....

FILED

Apr 24, 2019

SERIAL

88399984

REG#

Owner

Applicant

Imbria Pharmaceuticals, Inc.

Entity

Corporation

State

Address

20 Park Plaza #439, Boston, MA, 02116

Country

Attorney

NameMark S. Leonardo

Law firm

MARK S. LEONARDO BROWN RUDNICK LLP

Docket

34944/36

Address

ONE FINANCIAL CENTER, BOSTON, MA 02111, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateApr 24, 2019

Serial Number88399984

Registration No.0

Status DateJul 29, 2019

Mark TypeDesign with words

Attorney Docket34944/36

Status DescriptionDead and abandoned due to express abandonment

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

10 events

ABANDONMENT - EXPRESS MAILED

Jul 29, 2019

ABANDONMENT - EXPRESS MAILED

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

Jul 29, 2019

ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT

TEAS EXPRESS ABANDONMENT RECEIVED

Jul 26, 2019

TEAS EXPRESS ABANDONMENT RECEIVED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 12, 2019

NOTIFICATION OF NON-FINAL ACTION E-MAILED

NON-FINAL ACTION WRITTEN

Jul 12, 2019

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jul 12, 2019

NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Jul 04, 2019

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE E-MAILED

May 10, 2019

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 09, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Apr 27, 2019

NEW APPLICATION ENTERED

IMBRIA PHARMACEUTICALS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Imbria Pharmaceuticals, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Mark S. Leonardo

Resources

Company